Ning Li | Gene Regulations | Best Researcher Award

Posted on by PencisLeave a Comment on Ning Li | Gene Regulations | Best Researcher Award

Dr. Ning Li | Gene Regulations | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Li Ning, Ph.D. šŸ§¬

Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine

Research Areas :šŸ§ 

  • Molecular mechanisms of traumatic injury
  • Immunotherapy
  • Mechanobiology

šŸ“§ Email: lining620@tju.edu.cn

Brief Introduction:

Dr. Li Ning received her Ph.D. from Nankai University, China, in 2019. Since then, she has been a dedicated lecturer at Tianjin University, where she also supervises master's students. Her research delves into the pathogenic mechanisms of trauma, cell death in trauma-related diseases, immunotherapy, and biomechanics within disaster medicine. Dr. Ning has led numerous national, provincial, and university-level research projects, with her work published in esteemed journals like Nucleic Acids Research, Military Medical Research, Trends in Pharmacological Sciences, Cell Death & Discovery, and Pharmacological Research.

Educational Background šŸŽ“

  • 2008.09 - 2012.07: Bachelor's in Bioscience and Biotechnology, Shenyang Agricultural University
  • 2012.09 - 2015.07: Master's in Medicine, Nankai University
  • 2015.09 - 2018.12: Ph.D. in Pharmacy, Nankai University

Professional Experience šŸ’¼

  • 2019.05 - Present: Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine, Tianjin University

Academic Achievements:

Dr. Li Ning has an impressive list of published research papers, several of which highlight her contributions to the understanding of cell death mechanisms and potential therapeutic targets for trauma management. Additionally, she holds multiple patents, including innovations in nucleic acid detection and crush injury modeling equipment.

Fellowships & Honors šŸ†

  • Excellent Master's Thesis, Nankai University (2015)
  • Teaching and Educating Excellence Award, Tianjin University (2022)
  • Scientific Research Rookie Award, Tianjin University (2022)
  • Outstanding Mentor, Tianjin University (2023)
  • Multiple awards for outstanding contributions and excellence in teaching from Tianjin University (2022-2024)

Dr. Ning continues to contribute significantly to the fields of disaster and emergency medicine through her research and teaching.

Journal Publications šŸ“š

  • Nucleic Acids Research
    • Li Ning might have contributed research on the molecular mechanisms of traumatic injury, possibly focusing on DNA damage and repair mechanisms or gene expression changes post-injury.
  • Military Medical Research
    • Research related to trauma, particularly in military settings, could include studies on immunotherapy and the impact of cell death on traumatic injuries, as well as advances in medical biomechanics.
  • Trends in Pharmacological Sciences
    • Likely publications could discuss cutting-edge approaches in immunotherapy or pharmacological interventions targeting trauma-induced pathogenesis.
  • Cell Death & Discovery
    • Studies on the role of cell death in trauma-related diseases, focusing on molecular pathways and therapeutic targets.
  • Pharmacological Research
    • Research papers could include findings on drug interventions for trauma-induced pathologies, including immunotherapeutic strategies and their mechanobiological implications.

Notable Publications šŸ“‘

"Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment"Ā 

  • Authors: Qiao, O., Wang, X., Wang, Y., Li, N., Gong, Y.
  • Journal: Journal of Advanced Research
  • Year: 2023

"Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies"Ā 

  • Authors: Li, N., Han, L., Wang, X., Zhang, L., Gong, Y.
  • Journal: Translational Research
  • Year: 2023

"Delayed step-by-step decompression with DSF alleviates skeletal muscle crush injury by inhibiting NLRP3/CASP-1/GSDMD pathway "

  • Authors: Li, N., Wang, X., Wang, Y., Fan, H., Gong, Y.
  • Journal: Cell Death Discovery
  • Year: 2023

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARĪ±-mediated fatty acid oxidation"

  • Authors: Yu, J., Du, Y., Liu, C., Wang, Y., Qin, J.
  • Journal: Life Sciences
  • Year: 2024

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARĪ±-mediated fatty acid oxidation"

  • Authors: Xie, Y., Shan, M., Yu, J., Lan, L., Wang, Y.
  • Journal: Cancer Science
  • Year: 2024

Hongmeng Su | Gene Regulations |Ā Best Researcer Award

Posted on by PencisLeave a Comment on Hongmeng Su | Gene Regulations |Ā Best Researcer Award

Dr. Hongmeng Su | Gene Regulations and Epigenetics |Ā  Best Researcer Award

Southeast University | China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Hongmeng Su embarked on an academic journey marked by a strong foundation in bioengineering, which laid the groundwork for subsequent achievements. Graduating with a Bachelor of Engineering in Bioengineering from Nanjing Agriculture University in 2019, Su's early academic pursuits showcased a dedication to biological sciences and a burgeoning interest in research.

PROFESSIONAL ENDEAVORS

Transitioning seamlessly from undergraduate to graduate studies, Su pursued a Master of Science in Biology at the School of Life Science and Technology, Southeast University, from 2019 to 2021. This period not only honed Su's research skills but also provided a platform for academic growth and exploration in the field of biology.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATIONS AND EPIGENETICS

Su's contributions to the field of medical genetics and developmental biology are underscored by a multifaceted approach to understanding the molecular mechanisms driving hepatocellular carcinogenesis. Through meticulous research endeavors, Su has delved into the intricate interplay between non-coding RNA, transcription factors, and carcinogenesis, shedding light on key pathways implicated in cancer progression and metastasis.

IMPACT AND INFLUENCE

Su's research findings have garnered recognition and accolades, affirming the significance of their contributions to the scientific community. Notably, Su's report on the combined analysis of m6A and m5C RNA methylation modulators received honorable mention at the 10th Member Congress and Academic Seminar of Jiangsu Genetic Association, showcasing the impact of their work on hepatocellular carcinoma prognosis.

ACADEMIC CITATIONS

Su's scholarly endeavors have contributed to the advancement of knowledge in medical genetics, developmental biology, and cancer research. Their publications serve as a testament to their dedication to scientific inquiry and the dissemination of impactful findings within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As a Ph.D. candidate at the Department of Medical Genetics & Developmental Biology, School of Medicine, Southeast University, Su's legacy is characterized by a commitment to unraveling the complexities of hepatocellular carcinogenesis. Armed with a diverse skill set encompassing molecular and cellular experimentation, bioinformatics analysis, and statistical modeling, Su is poised to make enduring contributions to the field of cancer biology and beyond. Their future endeavors hold the promise of further elucidating the molecular underpinnings of cancer progression, informing novel therapeutic strategies, and ultimately, advancing human health.

Notable Publications

TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p 2021(35)

ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression

Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma